World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00313105
Date of registration: 10/04/2006
Prospective Registration: No
Primary sponsor: University Hospital, Gentofte, Copenhagen
Public title: Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
Scientific title: Smoking Cessation by Nurses With Smokeless Tobacco Buccal Tablets, Nicotine Buccal Tablets, Nicotine Patches With Repeated Therapy Every 6 Months for 2 Years
Date of first enrolment: April 2006
Target sample size: 600
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT00313105
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 2/Phase 3
Countries of recruitment
Denmark
Contacts
Name:     Philip Tønnesen, M.D., Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Chair dept. pulm. medicine, Gentofte Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- smokers (>7 cig/day)

- Healthy

- Allowed: treated hypertension, diabetes treated with tablets, increased
cholesterol,other "mild" diseases

- mild asthma and COPD,

- Motivated to quit smoking

- Motivated to follow the protocol

- Motivated to use medication in this trial

Exclusion Criteria:

- Severe diseases

- Psychiatric diseases

- Used NRT or Zyban the last 2 weeks

- Stopped smoking >2 days during last 3 months

- More than 6 alcoholic drinks per day

- Smokes other products than cigarettes

- Pregnant of lactating



Age minimum: 25 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Tobacco Dependence
Intervention(s)
Behavioral: smoking cessation counseling
Drug: Smokeless tobacco (Oliver Twist pellets)
Primary Outcome(s)
Abstinence from smoking after ½ year (point and continuous abstinence) [Time Frame: 6 months from entry]
Secondary Outcome(s)
Changes in cholesterol, blood-pressure, lung function, body-weight across smoking status [Time Frame: 6,12,24 months from entry]
Adverse events between 3 arms [Time Frame: Up to 6 months from entry]
Effect of retreatment (abstinence after 1, 1½ and 2 years) [Time Frame: 12,18 and 24 months from entry]
Adherence to study [Time Frame: 6,12,24 months from entry]
Biomarkers of inhalation between 3 arms (p-cotinine and p-thiocynate and u-NNAL) [Time Frame: 3 and 6 months from entry]
Secondary ID(s)
2005-004626-10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Danish Research Foundation, FSS, Copenhagen, Denmark
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history